None
Brief news summary
Australian researchers from Monash University have developed a new artificial intelligence (AI) tool called PSICHIC (PhySIcoCHemICal) that can revolutionize virtual screening in early-stage drug discovery. PSICHIC uses sequence data and AI to accurately predict the strength of interactions between molecules and proteins, eliminating the need for costly and less accurate processes. The tool has been able to effectively screen new drug candidates and perform selectivity profiling, distinguishing the functional effects of the compound. PSICHIC enhances the affordability and accuracy of drug discovery by eliminating the requirement for 3D structures and providing faster and more effective screening of drug compounds. The tool has been made available to the scientific community.Australian researchers from Monash University have developed a new artificial intelligence (AI) tool called PSICHIC (PhySIcoCHemICal) that can revolutionize virtual screening in early-stage drug discovery. The tool utilizes AI and sequence data to accurately predict protein-molecule interactions, eliminating the need for costly 3D structures. PSICHIC has shown promising results in screening new drug candidates and distinguishing their functional effects.
The researchers believe that AI has the potential to transform the landscape of drug discovery, and PSICHIC can significantly improve the accuracy and affordability of the process. The team has made their data, code, and optimized model available to the scientific community.
Watch video about
None
Try our premium solution and start getting clients — at no cost to you
